The journey of 1-Stearoyl-sn-glycero-3-phosphocholine reflects wider changes in biochemistry and medicine. Decades ago, when lipid scientists first started digging deeper into cell membranes, they uncovered a class of molecules called phospholipids that made up the backbone of biological membranes. Phosphatidylcholines, including 1-Stearoyl-sn-glycero-3-phosphocholine, turned out to be a star component. Early extraction methods looped through a gauntlet of solvents and column chromatography, often producing inconsistent yields. As chromatography evolved and synthetic organic chemistry matured, labs managed to isolate and even assemble these molecules with greater purity and reliable repeatability. This reliability meant researchers could experiment and, more importantly, trust the actual identity of the molecule. New synthetic methods also let researchers play around with the fatty acid tails, exploring what each tweak did for the behavior of the molecule in membranes and in commercial uses.
1-Stearoyl-sn-glycero-3-phosphocholine stands out as a single-component phosphatidylcholine, which means one fatty acid (stearic acid, an 18-carbon saturated chain) hooks onto the sn-1 position of the glycerol backbone. The rest of the structure includes a phosphate group bound to choline. In plain terms, this lipid has a hydrophilic ‘head’ and a long, oily ‘tail’, giving it the classic amphiphilic character that lets it hold together the watery and fatty parts of a cell membrane. Its structure lets it self-assemble into a variety of forms, such as vesicles or bilayers, making it essential for anyone tinkering with drug delivery, food emulsions, or biomembrane models.
1-Stearoyl-sn-glycero-3-phosphocholine brings some hardwired behaviors to the table. Its highly ordered saturated tail stands up well to oxidation compared to unsaturated siblings, making the molecule both durable and stable in many conditions. It’s a white to off-white solid at room temperature, and its melting point hovers well above that of natural lecithins with mixed fatty acids, largely because of the tight packing of saturated stearic chains. The molecule dissolves nicely in chloroform, methanol, and ethanol, but stays stubbornly insoluble in water unless it self-assembles into colloidal structures. The molecule bears both positive (choline) and negative (phosphate) charges, but remains neutral overall, which becomes important for its surface activity and compatibility with biomimetic systems. The high phase transition temperature of this phospholipid catches the eye in liposome formulation work, since it resists becoming fluid at physiological temperatures and can stabilize delivery systems.
Clear labeling gains particular importance with substances like 1-Stearoyl-sn-glycero-3-phosphocholine. Scientists and technicians expect purity levels to meet the 98% threshold for research work, with specific reporting on residual solvents and any possible degradation products. Labeling ought to reflect the synthetic or natural source, as biological contaminants raise concerns across labs and commercial applications. Molecular weight (commonly reported as 567.77 Da for 1-Stearoyl-sn-glycero-3-phosphocholine), lot number, and expiration dates form the backbone of technical documentation, creating traceability across experiments and batches. Freeze-dried storage, with tight protection against moisture, preserves sample integrity. Lab staff would expect certificates of analysis covering heavy metals, microbiology, and solvent residues, linking chemical identity to safe handling and compliance.
Building this molecule in a lab setting most often starts with commercially available sn-glycero-3-phosphocholine, followed by chemical acylation with stearoyl chloride or related derivatives. This process normally unfolds in anhydrous solvents under nitrogen to keep moisture and unintended reactions at bay. Any leftover reactants or unwanted side products get cleared out using column chromatography. Early research teams lacked this level of chemical finesse, squeezing mixtures from natural lecithin with tedious fractionation, never really sure what mixed in. Synthetic advances put the power into the hands of researchers, who now walk a more controlled path from the starting material to the pure product. Some innovative approaches from the last decade swap out harsh acylation steps for enzymatic routes, giving cleaner products with potentially lower environmental burden.
The saturated nature of the stearoyl tail means it stays resistant to most unintended chemical modifications, especially compared with phospholipids containing unsaturated chains, which become prone to oxidation. Researchers sometimes use mild hydrolysis, phospholipase enzymes, or targeted exchange reactions to swap the choline headgroup or to snip off the fatty acid chain for analytical work. The structure gives a platform for designing analogs tailored for specific medical or industrial aims. In the pharmaceutical world, laboratories often peg polyethylene glycol (PEG) or other functional side chains onto the molecule, granting stealth properties to drug carriers. Crosslinks, fluorophores, or radioisotopes can graft onto the headgroup site, generating probes for imaging or tracking the fate of vesicles in living systems.
Common naming conventions still tie researchers in knots, since the same substance appears under synonyms like 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine, Stearoyl-lyso-PC, or 1-Stearyl-lysophosphatidylcholine. These names often reflect subtle differences in regional preference or commercial branding. Abbreviations like "stearyl-LPC" or "lysoPC(18:0/0:0)" pop up across literature and catalogs, creating a bit of a maze unless one studies the actual molecular structure in detail. Product codes from suppliers don’t ease the confusion, so anyone using the molecule for precise work needs to stay sharp about which isomer or purity grade they’re actually handling.
Most lab staff can handle 1-Stearoyl-sn-glycero-3-phosphocholine safely by sticking to standard protocols for powdered biochemicals. The low volatility and resistance to spontaneous reactions mean the risk profile stays lower than many industrial chemicals. Inhalation of dust brings respiratory risk, and chronic skin contact best not be ignored, since any fine particulate poses irritant risk, and the choline headgroup offers membrane-permeability advantages that could, in principle, shuttle the molecule across biological barriers. Proper gloves, dust masks, and bench venting suffices for routine use. Disposal follows the rules for organic chemicals, especially liquids with trace organic solvents, but this molecule avoids strict hazard classifications in most regulatory settings. Labs and production plants keep logs, storage audits, and standard operating procedures in place, leaning on international standards like ISO/IEC 17025 for analytical work and ISO 9001 for production tracking.
Researchers started working with 1-Stearoyl-sn-glycero-3-phosphocholine as a model for pure phosphatidylcholine behavior, using it in structural studies of lipid bilayers and vesicles. Over time, this molecule shifted from lab bench curiosities into high-value ingredients for drug delivery, especially in liposome and nanoparticle design. Its ability to hold together artificial membranes, buffer cargo, and slow down leakage kept it in the sights of drug formulators looking for controlled release and targeted therapies. The prevalence of synthetic lipid nanoparticles in mRNA vaccine work drew fresh attention to molecules in this class. Food scientists have explored purified phospholipids for emulsifying properties not found in cheap lecithin blends, chasing longer shelf life and improved texture in certain products. New biotechnological tweaks aim to program the surface properties of 1-Stearoyl-sn-glycero-3-phosphocholine, nudging immune responses or facilitating uptake into select tissues.
Research into the roles of different lysophosphatidylcholines, including 1-Stearoyl-sn-glycero-3-phosphocholine, now leans more and more on precision synthesis and high-throughput screening. Scientists probe stability, membrane fluidity, and compatibility with proteins, hunting for lipid blends that outperform natural analogs in therapeutic applications. Some labs explore targeted modifications that could tune the molecule for longer blood circulation or more effective payload delivery across cell barriers. With computer modeling, researchers simulate how minor chemical edits ripple out to affect assembly, fusion, or interaction with biological systems—work that shapes the next breakthroughs in drug development. The R&D cycle between academia and industry keeps quickening, supported by better data analytics and advances in chemical synthesis.
Toxicological studies don’t always make headlines, but they sit at the base of every application of 1-Stearoyl-sn-glycero-3-phosphocholine. So far, most data frame it as low-risk, referencing that similar phospholipids exist throughout the body, but that doesn’t let anyone skirt detailed analysis. Acute exposure in animal models points to high thresholds for irritation or systemic effects, but long-term exposure or interactions with other compounds remain an active area of inspection. Regulatory guidelines press for ongoing surveillance, especially as more complex nanoparticles or synthetic analogs reach clinical trials and consumer products. Vigilance remains a virtue, since subtle effects sometimes only surface years after commercial roll-out.
Interest in 1-Stearoyl-sn-glycero-3-phosphocholine points to a future with more precise biochemistry, smarter medicine, and deeper understanding of how simple chemical structures bend the arc of innovation. Synthetic improvements, such as greener enzymatic routes, suggest cleaner, more scalable production lines. Researchers keep looking for ways to optimize the interaction between lipid components, targeting specific tissues, or wrapping up unstable therapeutic agents for safe transit inside the body. Work doesn’t stop at medical frontiers—there’s a growing push in food technology and biomaterial engineering. Environmental monitoring, open-access safety data, and constant improvements in analytical methods mean this molecule will stay in the spotlight as both a research platform and a commercial ingredient. With each wave of new research, the balance between reward and responsible use sharpens, illustrating the path for responsible innovation in lipid chemistry.
1-Stearoyl-sn-glycero-3-phosphocholine sounds like something you’d only bump into in a chemistry lab. The truth is, this compound isn't just hiding on a professor’s shelf; it shows up in some corners of human health you might not expect. Scientists call it a lysophospholipid. It’s got a role in our bodies—part of the membrane around every single cell. Having spent time talking to folks in nutrition and drug development, I’ve seen how one small molecule can show up in surprising ways.
Doctors and researchers turn to 1-Stearoyl-sn-glycero-3-phosphocholine primarily for its part in cell signaling and membrane structure. It plays a strong supporting role in making sure nerve cells send messages the way they’re supposed to. In the lab, researchers use it when they need to patch together artificial cell membranes. This helps them see how certain drugs or toxins will react in a setting that’s close to nature. If someone is developing a treatment that targets nerves, or needs to deliver medicine across a tricky cellular barrier, they might turn to this compound for clues.
Brain health research has paid attention to these types of phospholipids. Some studies suggest these molecules help regulate neurotransmitter release and protect cells from stress. Though there’s a lot we don’t know yet, the work is promising for conditions like Alzheimer’s and stroke recovery. I remember reading about early studies—done with very basic equipment—that opened the door to new treatments because of this molecule’s presence during brain injury. Today’s labs can dig much deeper thanks to better analytical tools and deeper knowledge of cell mechanics.
Some manufacturers add lysophospholipids to nutritional supplements focused on cognitive health. They claim these ingredients support memory and focus, especially in products aimed at older adults. Science on the direct effects of 1-Stearoyl-sn-glycero-3-phosphocholine in supplements is still early. Studies on related phospholipids, such as phosphatidylcholine, give a hint that benefits could extend to this compound—but strong, large-scale evidence hasn’t arrived yet.
Cosmetic companies sometimes include lysophospholipids to help skin creams spread evenly and blend better with the natural oils in skin. The real driver is the similarity between these molecules and the ones in cell membranes. This makes absorption smoother. In practice, people who try these creams say they often feel less greasy than oil-based products. That comes from the molecular structure letting water stick around a bit longer on the skin’s surface. Still, more research is needed to confirm any long-term benefit beyond how it feels after application.
Although 1-Stearoyl-sn-glycero-3-phosphocholine sounds safe, the lack of large, long-term studies means there’s some risk when using new supplements. Over the years, several ingredients landed in stores before anyone fully understood how they work in the body, which sometimes led to problems. It helps to ask questions, read research, and consult with healthcare professionals before starting anything unfamiliar. More focused studies on dosing, absorption, and real-world impacts will help sort out fact from wishful thinking in the next few years.
If research keeps moving forward, this molecule may help lead to smarter drug delivery systems or more useful supplements. Scientists and companies often work together on these challenges, trading knowledge and resources along the way. As with so many discoveries, success in this field comes down to patience and good data, not hype.
The name “1-Stearoyl-sn-glycero-3-phosphocholine” sounds intimidating, tangled up in scientific jargon. Strip away the complexity, and you’re talking about a kind of phospholipid. Phospholipids pop up everywhere—most notably in the membranes of our cells. This particular molecule comes from stearic acid and choline, two substances with long histories in food and human biology.
Phospholipids. That word brings back memories of biology class, staring into a microscope or tracing the boundary of a cell in a textbook. They're in eggs, soybeans, and even sunflower oil. Our bodies already deal with similar compounds every day. The key here is that 1-stearoyl-sn-glycero-3-phosphocholine isn’t some alien invader; it fits right into biological processes like membrane repair and signaling between cells.
Dig into the studies. Researchers have tested this compound in various settings. It’s often found in research as a supplement or used to model cell membranes in medical studies. No flags go up in animal data, even at levels much higher than what would show up in normal foods. The European Food Safety Authority and U.S. FDA both keep an eye on substances in this family, and so far, long-established food lecithins—rich in similar phospholipids—get a clean bill of health.
One thing stands out: most safety data treat this class of molecules as safe to eat, since they've been present in common foods for ages. Toxicity studies—sometimes poking at doses way above what anyone would eat—don’t turn up nasty surprises. Human studies involving lecithin, which is full of molecules like 1-stearoyl-sn-glycero-3-phosphocholine, report no obvious adverse effects. Folks eating balanced diets are probably already ingesting these phospholipids in small doses every day.
Companies have tinkered with adding phospholipids to nutrition bars, infant formulas, and specialty products for years. Lecithin, often loaded with similar molecules, works as an emulsifier, blending fat and water together. Despite the chemical complexity, the safety record keeps looking strong. The problem rarely comes from the molecule itself—it’s more about what comes with it. Purity matters, especially for compounds extracted from soy or egg, since traces of allergens could slip through.
Some questions still hang in the air, particularly when these compounds get isolated and pushed to higher doses. Experience with lecithin shows allergic reactions can pop up, mostly because of trace proteins rather than the phospholipids themselves. Choline-heavy supplements sometimes produce odd side effects like a fishy odor or slight drops in blood pressure, but those cases involve big doses.
For folks worried about what lands on their plate, transparency helps. Look for clear labeling, especially if you have allergies or sensitivities. If you see 1-stearoyl-sn-glycero-3-phosphocholine listed on a label, it pays to ask where it came from—egg, soy, or something else. Value is in trust and traceability, especially as novel ingredients show up in more foods.
We’ve reached a point where the evidence backs up the safety of 1-stearoyl-sn-glycero-3-phosphocholine at the levels found in food and supplements. Pushing the dose sky-high or ignoring potential allergens isn’t smart, but ordinary consumption fits comfortably within scientific consensus and generations of dietary habits.
Once you start reading up about molecules in biology, especially phospholipids, the names get pretty dense before you even meet the science. 1-Stearoyl-sn-glycero-3-phosphocholine is no exception—a big name for a pretty fundamental player in human biology. For the curious, its molecular formula is C26H54NO8P. That doesn't exactly roll off the tongue, but it represents a structure with real importance.
That sequence of carbon, hydrogen, nitrogen, oxygen, and phosphorus isn’t just a code for chemists to memorize. It tells a story about design. The 26 carbons come mostly from its stearic acid component, an 18-carbon saturated fatty acid. The glyceryl backbone hooks up with the fatty acid at one end, and then at another, you’ve got the phosphate group linked to choline.
If you’ve ever looked at a textbook diagram of a cell membrane, phosphatidylcholines like this are often front and center. They have a “tail” and a “head,” and that structure lines up with their roles—one side attracted to water, the other repelled, drawing out the assembly that shields our cells.
Life at the molecular level shapes our everyday health, from how our bodies absorb nutrients to how drugs make their way to targets inside cells. This particular lipid helps keep cell membranes flexible but stable, supporting everything from nerve cell signaling to the packing of lung surfactants. Without these molecules, cell membranes would lose integrity, causing all sorts of trouble for tissues and organs.
You will find 1-Stearoyl-sn-glycero-3-phosphocholine in food, especially in eggs and soy, but its impact stretches beyond diet. It has plays a significant role in drug delivery research, especially where scientists need molecules that mimic the human membrane. This helps design treatments that slip past the body’s natural barriers or helps experimental therapies stay active inside the body.
One of the biggest obstacles for biochemists lies in sourcing pure forms of these lipids for clinical research. Lipid extraction from natural sources can bring contaminants, throwing off experiments or making outcomes unreliable. Synthetic routes improve purity but can run up the cost and introduce new hurdles when you try to scale up production for testing or nutrition studies.
Being able to create and work with defined molecules like 1-Stearoyl-sn-glycero-3-phosphocholine pushes forward a lot of areas in medicine. Getting quality raw materials makes a difference in whether a new drug delivery method works or falls short. Factoring in environmental impact, sustainable production practices also demand attention, since typical extraction methods can waste resources or use hazardous chemicals. We gain by encouraging methods that recycle solvents, use renewable feedstocks, and reduce hazardous waste.
Researchers now have more tools—like mass spectrometry and nuclear magnetic resonance (NMR)—to make sure what they’ve made is what they intended, right down to the last atom. Regulations and quality control standards keep watch over the entire process, not just for safety, but so other labs worldwide can trust the same material will behave as expected. All these efforts pay off in the shape of quicker advances in medicine and nutrition, impacting how society manages health at every level.
Anyone who’s handled biological chemicals knows the value of getting storage right. I think about freezer burn in the home kitchen—a waste if you let it happen, and it stings harder when the lost stuff cost a fortune or delays the experiment. 1-Stearoyl-sn-glycero-3-phosphocholine, often part of lipid research and pharmaceutical projects, needs thoughtful attention. Missteps don’t just ruin the sample. They can set back a whole line of work.
1-Stearoyl-sn-glycero-3-phosphocholine breaks down under heat, moisture, and light. This gets personal for folks who’ve watched a lipid film cloud up under the wrong conditions. After seeing a pricey batch spoil on a cluttered benchtop, I always reach for a -20°C freezer for phospholipids like this one.
Keep the vial tightly sealed. Any air creeping in brings water vapor, and enough humidity will push the lipid to clump or degrade. Most suppliers pack it up in amber bottles to block the light; don’t ditch this packaging even if another container looks handier. Photodegradation sneaks up quietly and then the next TLC run shows smears everywhere.
Many researchers overlook the effect of temperature cycles. Some try to store all reagents together for convenience, but frequent thawing and freezing causes condensation. I learned quickly to pull only the small working aliquot, leaving the rest undisturbed deep in the cold.
In busy labs, labeling often gets rushed—“I’ll remember, it’s the only tube on the left.” That’s wishful thinking. I make it a habit to note the date, full chemical name, and even concentration or solvent. Don’t trust memory. Handwriting blurs, tubes roll under flasks, and months later you’re left with unidentified white powder.
Security against contamination also means using clean spatulas, gloves, and, if possible, single-use tips. No one wants microdroplets from a pipette tip introducing uncertainty, especially in a series of fine lipid assays. Cross-contamination sabotages reproducibility, and journals take reproducibility seriously.
Years of lab work taught me how little patience most people have for storage protocols that seem fussy or hard to follow. But shortcuts multiply risks. Labs often bring together a mix of experience levels—the new postdoc and the senior tech may not treat a rare compound the same way. When teams work fast or use makeshift solutions, something always suffers. It pays off to build a culture where double-checking vials, sticking to freezer logs, and laying out a clear shelf-space system becomes routine.
If you manage shared spaces, invest in backup freezers with alarms. Power cuts, accidental door openings, or plain old overcrowding lead to silent losses. After coming in one morning to find that a tripped circuit breaker spoiled half the cold room, I never ignore backup systems again.
Lots of new lab members enter with little exposure to high-value lipid compounds or custom chemicals. I recommend periodic briefings, visible SOPs near every storage unit, and regular checks—not just to enforce policy, but to show why it matters. Research thrives on shared knowledge, and those few minutes spent safeguarding chemicals protect months of hard work. For a compound as crucial as 1-Stearoyl-sn-glycero-3-phosphocholine, storing it with real care makes the difference between frustration and a project that moves forward smoothly.
In the world of cell membranes and lipid research, some compounds just never fall out of favor. 1-Stearoyl-sn-glycero-3-phosphocholine, often shortened to 18:0 PC by people who work with it, always finds space on my shelf and in those of scientists worldwide. It stands as a standard phospholipid for making model membranes and liposomes — the basic building blocks for understanding how cells work, break, and interact with molecules.
Every time I want to mimic cellular membranes, I turn toward 18:0 PC. Its single saturated stearoyl chain brings reliable stability, allowing researchers to build what we think of as “pure” or “clean” bilayers. These bilayers become platforms for studying protein-lipid interactions, membrane fluidity, or drug penetration. What amazes me is how, by mixing it with other lipids, I can watch changes in a membrane’s properties almost in real time, using tools like NMR or fluorescence microscopy. Lipid rafts, domain formation—much of what we know comes from experiments starting with 1-Stearoyl-sn-glycero-3-phosphocholine.
Pharmaceutical researchers don’t just study membranes for fun. Liposomes made with 1-Stearoyl-sn-glycero-3-phosphocholine serve as vehicles for delivering drugs directly to targeted cells. I’ve worked alongside teams that rely on its biocompatibility to create nanoparticles that evade immune detection and carry chemotherapy or gene therapy payloads right to the source. It helps with encapsulating hydrophobic drugs, tweaking release profiles, and minimizing side effects, all of which keeps patients safer and treatments more effective.
I’ve watched 1-Stearoyl-sn-glycero-3-phosphocholine stir up breakthroughs in research into lipid signaling and metabolism. It’s a go-to substrate in enzyme assays, especially for enzymes like phospholipases. By using labeled versions, researchers can chase the fate of a lipid through a maze of metabolic pathways, opening up clues to diseases linked with lipid mismanagement—think cardiovascular disease or inflammation. The path from fundamental questions to medical relevance often runs right through simple experiments with this phospholipid.
People sometimes worry about using animal-derived products in the lab, especially now when reproducibility and animal welfare raise tough questions. Synthetic production of 1-Stearoyl-sn-glycero-3-phosphocholine has dramatically reduced these concerns. Suppliers provide materials that meet high standards for purity, minimizing batch-to-batch variation and ensuring consistent results. When I train new researchers, I remind them to cross-check sources, run controls, and trust — but always verify — what’s inside their vials. This mindset, combined with transparent reporting and cross-lab collaboration, helps build robust findings you can depend on.
Lipidomics now offers crystal-clear snapshots of membrane composition in different cells and disease states. 1-Stearoyl-sn-glycero-3-phosphocholine serves as a reference standard in mass spectrometry analysis, ensuring accuracy in every run. Its simplicity underpins complex discoveries. I wouldn’t call it glamorous, but its reliability keeps research moving forward, bridging the gap between chemistry, biology, and medicine. Lab routines may change, but some tools—like this phospholipid—prove their worth again and again.
| Names | |
| Preferred IUPAC name | 2-(stearoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate |
| Other names |
LysoPC 18:0 Stearoyl lysophosphatidylcholine 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine Stearoyl-LPC 1-Stearoyl-LPC |
| Pronunciation | /wanˈstɪə.rɔɪl.sn.ɡlɪˈsɪə.roʊ.θriː.fɒs.foʊˈkoʊ.lin/ |
| Identifiers | |
| CAS Number | 36021-16-4 |
| Beilstein Reference | 1713885 |
| ChEBI | CHEBI:74768 |
| ChEMBL | CHEMBL1230942 |
| ChemSpider | 2260992 |
| DrugBank | DB02595 |
| ECHA InfoCard | EC 277-154-4 |
| EC Number | 3.1.1.4 |
| Gmelin Reference | Gmelin Reference: "107502 |
| KEGG | C04230 |
| MeSH | D025261 |
| PubChem CID | 5283563 |
| RTECS number | SI9663000 |
| UNII | 3K7A0SQE6V |
| UN number | UN number not assigned |
| Properties | |
| Chemical formula | C26H54NO8P |
| Molar mass | 789.1 g/mol |
| Appearance | White to off-white powder |
| Odor | Odorless |
| Density | 1.030 g/cm³ |
| Solubility in water | Insoluble |
| log P | 3.6 |
| Vapor pressure | 6.14E-30 mmHg at 25 °C |
| Acidity (pKa) | 1.00 |
| Basicity (pKb) | 1.70 |
| Magnetic susceptibility (χ) | -76.0 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.465 |
| Viscosity | Viscous liquid |
| Dipole moment | Dipole moment of 1-Stearoyl-sn-glycero-3-phosphocholine is 25.1566 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 840.6 J/(mol·K) |
| Std enthalpy of formation (ΔfH⦵298) | -1470.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -9192.7 kJ/mol |
| Pharmacology | |
| ATC code | A04AD06 |
| Hazards | |
| Main hazards | Not a hazardous substance or mixture. |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Precautionary statements | Precautionary statements: P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P362+P364, P501 |
| Flash point | > 230 °C |
| LD50 (median dose) | LD50 Intravenous - Mouse - 112 mg/kg |
| NIOSH | Not assigned |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for 1-Stearoyl-sn-glycero-3-phosphocholine is not established. |
| REL (Recommended) | 0.5 mg/m³ |
| Related compounds | |
| Related compounds |
1,2-Distearoyl-sn-glycero-3-phosphocholine 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine LysoPC (16:0) Glycerophosphocholine 1-Oleoyl-sn-glycero-3-phosphocholine |